Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jun 27, 2025
- Accession no.
- 0001562180-25-005102
- Filed
- Jun 27, 2025
- Trade date
- Jun 26, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.14M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2025 | Common Stock | MOption exerciseAcquired | +11,000 | $135.42 | +$1,489,620 | 47,781 | Direct | |
| Jun 26, 2025 | Common Stock | SSaleDisposed | −2,537 | $284.10F2 | −$720,761.7 | 45,244 | Direct | |
| Jun 26, 2025 | Common Stock | SSaleDisposed | −3,940 | $285.01F3 | −$1,122,939.4 | 41,304 | Direct | |
| Jun 26, 2025 | Common Stock | SSaleDisposed | −939 | $286.13F4 | −$268,676.07 | 40,365 | Direct | |
| Jun 26, 2025 | Common Stock | SSaleDisposed | −2,334 | $287.21F5 | −$670,348.14 | 38,031 | Direct | |
| Jun 26, 2025 | Common Stock | SSaleDisposed | −1,150 | $287.92F6 | −$331,108 | 36,881 | Direct | |
| Jun 26, 2025 | Common Stock | SSaleDisposed | −100 | $288.80 | −$28,880 | 36,781 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2025 | Common Stock | MOption exerciseDisposed | −11,000 | $0.00 | $0 | 121,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $283.52 to $284.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $284.52 to $285.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $285.60 to $286.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $286.60 to $287.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $287.60 to $288.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.